Skip to main content
. 2018 May 10;13(5):e0196552. doi: 10.1371/journal.pone.0196552

Fig 5. Allograft survival based on tacrolimus (Tac) predose concentrations (C0) ≤5.9 ng/mL vs. >5.9 ng/mL of c-aABMR patients (cases) and controls combined.

Fig 5